Phathom Pharmaceuticals Inc (PHAT)

Phathom Pharmaceuticals Inc (PHAT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $551M; returns 1 day -18.1%, 1 week -17.1%, 1 year -57.8%.

Phathom Pharmaceuticals Inc. (PHAT) is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, particularly acid-related disorders.

Groups PHAT belongs to

• Gastroenterology
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Digestive Health
• Healthcare
• Commercial Stage
• Commercial Stage Biotech
• Canada

PHAT financial model: income statement, cash flow and balance sheet